http___www.kakolijeciti.com_napokon-otkriven-lijek-za-hiv__1.xml
1.1 2.1 3.1 4.1 5.1 5.2 6.1 7.1 8.1 9.1 9.2 10.1 11.1 12.1 12.2 13.1 13.2 14.1 15.1 15.2 16.1 16.2 17.1
HIV & AIDS health centre Could UK scientists find a way to eradicate HIV? 3rd October 2016 - A collaboration between some of the top biomedical researchers in the UK may be making progress towards finding a cure for HIV. This month marks 6 years since five leading research establishments agreed to cooperate to try to find a solution to one of the world's greatest health challenges. HIV is a virus infection that is treatable using antiretroviral therapy (ART). Essentially ART works by stopping the HIV virus from spreading and gives the body's immune system a chance to recover. However, ART cannot cure HIV and if therapy stops, the virus will return. Helping the body's immune system fight back The new research, which is still in its early stages, involves using medication that encourages the body's immune system to fight and eradicate the disease. Only 50 people are involved in the trial at this stage, but the Sunday Times reported on growing hopes for an eventual cure by citing the case of one of them, a 44-year-old London man who contracted HIV and has since undergone treatment. The paper reports that early tests have found that the virus is now "undetectable" in his blood. However, the report also makes clear that the apparent absence of the virus could be attributable to the conventional medications that he has also been taking. Putting academic rivalry aside The medical consortium was the idea of Mark Samuels, managing director of the National Office for Clinical Research Infrastructure (NOCRI), part of England’s National Institute for Health Research. He brought together leading doctors, scientists and mathematicians from the universities of Oxford and Cambridge, Imperial College London, King's College London and University College London. At a meeting in October 2010 they agreed to put academic rivalry aside and contribute their expertise to finding a cure for HIV. Each member present agreed that they could provide a part of the jigsaw needed to find a cure, but could not achieve this in isolation, according to Mark Samuels. He says in a statement: "The competitive nature of the relationship between Oxford and Cambridge, spanning 800 years, is widely known, but there is also competition running across all these leading universities, particularly in terms of vying for research funding. "Yet here was an opportunity to put that competition aside, and collaborate on a global health challenge. As a result, the Medical Research Council awarded one of the first joint grants to these 5 leading biomedical research institutions. "And in return each research centre provides its expertise to complete the jigsaw needed to find a cure for HIV - from patients, to the right doctors, the right diagnostic technology, the mathematician to analyse results and so on. CHERUB was born." CHERUB stands for Collaborative HIV Eradication of Viral Reservoirs: UK BRC (biomedical research centres).
1.1 2.1 3.1 3.2 4.1 5.1 5.2 6.1 7.1 8.1 9.1 9.2
Napokon otkriven lijek za HIV? Nakon što je primio terapiju, iz krvi oboljelog virus je jednostavno nestao. Britanski znanstvenici možda su uspjeli izliječiti HIV. Naime, zaraženi muškarac podvrgnut je novoj terapiji, nakon čega je virus iz njegove krvi u cijelosti nestao, piše net.hr. Muškarac star 44 godine jedna je od 50 osoba koje su podvrgnute novoj terapiji, a u njegovoj krvi više nema virusa HIV-a. ‘Bilo bi odlično da je pronađen lijek. Posljednji testovi koji su obavljeni na mojoj krvi prije nekoliko tjedana nisu detektirali virus’, ispričao je muškarac iz Londona. Jeli ovo zapravo prvo potpuno izlječenje? Terapiju na kojoj je bio kreirao je tim znanstvenika sa pet britanskih sveučilišta: Oxford, Cambridge, Imperial College London, University College London i King’s College London. Znanstvenici tvrde kako nema traga virusu u krvi i ako tako ostane, radit će se o prvom potpuno izlječenju. ‘Istražujemo mogućnost izlječenja HIV-a. To je veliki izazov i još je rano reći, ali napredak je uistinu nevjerojatan’, kazao je Mark Samuels, direktor britanskog nacionalnog Instituta za zdravstvena istraživanja.